-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
June 16, 2010 - appears not to
meaningfully impact results.29,30
The development of intensified anti-neoplastic therapies … • Aranesp® is not indicated for use in patients receiving hormonal agents,
therapeutic biologic products … How do different criteria for discontinuing therapy or for optimal
duration of therapy compare as regards … Concomitant supportive treatments, e.g. … Did the control group receive the same care (e.g. chemotherapy and
supportive therapies) with or without
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-protocol.pdf
June 20, 2024 - , and behavioral therapy. … treatments), treatment pathways and evaluation of risk factors for surgical treatment failure. … , no
treatment, sham
KQ 6
• No therapeutic challenge;
(prognostic/predictive modeling study … Part 13: injection therapies, low-back pain, and
lumbar fusion. … Treatments for Acute Pain: A Systematic Review.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/trauma-interventions-maltreatment-child_research-protocol.pdf
January 12, 2012 - , the
Incredible Years, and attachment/holding therapy) … "[Mesh]
#28 Search #7 AND #27
#29 Search "Complementary Therapies"[Mesh]
#30 Search #7 AND #29 … "[tiab] OR "treatments"[tiab] OR
"therapy"[tiab] OR "therapies"[tiab] OR "therapeutic"[tiab] OR "training … Empirically Supported Treatments and Promising
Practices. … Rather, the model incorporates any evidence-based
therapeutic treatment designed to repair the relationship
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - It was
addressed as an outcome only for the balance,
exercise and physical therapy therapies. … One of the problems in these reviews is the lack of
any RCTs involving old therapies. … Peer reviewer #1 General For nonpharmacologic treatment options, specific
types of therapeutic footwear … No
treatments improved quality of life (low SOE). … is worth
considering, especially for people on chronic opiate
therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - It was
addressed as an outcome only for the balance,
exercise and physical therapy therapies. … One of the problems in these reviews is the lack of
any RCTs involving old therapies. … Peer reviewer #1 General For nonpharmacologic treatment options, specific
types of therapeutic footwear … No
treatments improved quality of life (low SOE). … is worth
considering, especially for people on chronic opiate
therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-271-mental-health-pregnant-disposition-comments.pdf
July 31, 2024 - Psychodynamic
therapies were not excluded
from this review. … have added a paragraph to
the discussion highlighting the
need for future research
assessing the therapeutic … components and combination of
therapeutic components that are
likely to be the most effective
across … compared with treatment as
usual. … compared with treatment as
usual.
-
effectivehealthcare.ahrq.gov/sites/default/files/clifford.pdf
May 29, 2025 - One of the components of this was creating an institution called the ALS
Therapy Development Institute … which is a non-profit that has done an enormous
amount of mouse work in retesting every available therapeutic … Then you can go down and you can see what treatments they take and why they take
the treatments and … what kinds of treatments they are. … study on adherence to guidelines,
where we looked at the guidelines that AAN put out for epilepsy treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
February 01, 2010 - patients with coronary disease; they apply only to
patients for whom either CABG or PCI is a reasonable therapeutic … The final
analysis of the Arterial Revascularization
Therapies (ARTS) randomized trial. … A
randomized controlled clinical trial of 3
therapeutic strategies for multivessel
coronary artery … Continuing evolution of therapy for
coronary artery disease. … Fibrinolytic Therapy Trialists' (FTT)
Collaborative Group.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-interventions-comparing_methods.pdf
November 01, 2008 - , the EHC Program relies on systematic review methods to
provide guidance on the effectiveness of therapeutics … harms of a range of options compare, rather than to answer a narrow question of whether a single
therapy … Equivalence of different treatments for a group of patients on average does not necessarily imply
http
-
effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_slutsky_comparing_medical_interventions.pdf
November 01, 2008 - , the EHC Program relies on systematic review methods to
provide guidance on the effectiveness of therapeutics … harms of a range of options compare, rather than to answer a narrow question of whether a single
therapy … Equivalence of different treatments for a group of patients on average does not necessarily imply
http
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-safety_research.pdf
July 01, 2009 - used across a range of practitioners, settings, and
demographic groups and the associated therapeutic … ; assessing long-term outcomes of treatments; and collecting new information about
therapies at the … very large individual databases and registries may not have a
sufficient number of cases to detect treatment … kidney disease in patients whose blood pressure remains
uncontrolled after initiation of 1st line therapy … Identify and characterize use of a newly-approved therapy, including users, dispensings,
and exposure
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
November 27, 2012 - In the
former, practitioners move to another therapeutic choice and in the latter,
study subjects drop … Although
therapies may be stopped after 12 to 16
weeks in patients who fail treatment, there
are patients … who are on these therapies
much longer than 16 weeks when therapies
are successful. … Thus, ustekinumab is by far the most convenient therapy. … Amgen has conducted many clinical trials in the
inflammation therapeutic area to demonstrate the safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_disposition-comments.pdf
January 01, 2010 - draft Key
Questions, AHRQ proposes a multifactorial
examination of a variety of combinations of
treatments … , and treatment
goals. … from Diabetes Care and our
other previous work published in Diabetes
Care, Diabetes Technology & Therapeutics … "Real-world" experience is
critical to understanding the effectiveness of
treatments for chronic illnesses … Studies by Rodbard
published in Diabetes Technology and
therapeutics in 2009, and Garg, published in
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - locoregional treatment, endocrine therapy, and
chemotherapy), with more locoregional therapy provided … The assignment of the patient to a particular therapeutic strategy is not decided in
advance by a trial … (e.g., the introduction of a
new therapy, introduction of new indication for existing therapy) may … Challenges for synthesising data in a
network of registries for systemic psoriasis
therapies. … Pharmacoepidemiological Research on
Outcomes of Therapeutics by a European
ConsorTium; 2015.
19
http
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
November 28, 2012 - In the
continuum of care, use of liver-directed therapies has traditionally preceded treatment with … Analytic framework for comparative effectiveness of local therapies for treatment
of unresectable primary … brachytherapy,
hypofractionated proton beam therapy)
• Transarterial therapies (TAE, TACE, RE,
DEBs … o Were concurrent/concomitant treatments clearly specified and given equally to
treatment groups? … Comparing
across these treatment
categories assumes
patients were eligible
for both treatments.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cardiology-health-outcomes_research.pdf
July 01, 2010 - Care Program Research Report Number 30
Introduction
Carotid endarterectomy has been the recommended treatment … publication of several randomized studies in the
1990s comparing carotid endarterectomy with medical therapy … The
overall rate of revascularization did not increase, even with the introduction of a new therapeutic … Ongoing clinical trials will provide critical guidance for the treatment of
patients who are eligible … Carotid surgery versus medical therapy in
asymptomatic carotid stenosis.
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia_horizon-scan-high_impact-1306-revised.pdf
July 09, 2013 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … this test is able to rule out AD), reduced need
for long-term care, and avoided use of ineffective therapies … at Point of This Intervention
Donepezil, rivastigmine, and galantamine are the primary FDA-approved therapies … Intranasal delivery
bypasses the blood-brain barrier to target
therapeutic agents to the central
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/bipolar-disorder-treatment_research-protocol.pdf
June 23, 2014 - We separated physically-based somatic treatments, such as
electroconvulsive therapy, into a third category … How do pharmacologic treatments (monotherapy or combination therapies) affect
patient centered outcomes … How do pharmacologic treatments (monotherapy or combination therapies) affect
patient centered outcomes … How do somatic treatments (electroconvulsive therapy (ECT), transcranial
magnetic stimulation (TMS)) … and social rhythm therapy
• Psychoeducation
• Chronotherapy
Somatic treatment treatment
• Electroconvulsive
-
effectivehealthcare.ahrq.gov/products/atherosclerosis-plaque/technical-brief
-
effectivehealthcare.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_2012-12-11.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address